Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

14 Nov, EOD - Indian

SENSEX 77580.31 (-0.14)

Nifty 50 23532.7 (-0.11)

Nifty Bank 50179.55 (0.18)

Nifty IT 42390.85 (0.05)

Nifty Midcap 100 54043.1 (0.45)

Nifty Next 50 67408.65 (0.46)

Nifty Pharma 21752 (-0.26)

Nifty Smallcap 100 17601.05 (0.81)

14 Nov, EOD - Global

NIKKEI 225 38233.12 (-1.06)

HANG SENG 19426.34 (-0.05)

S&P 5917.25 (0.15)

Cancel

BSE Code : 524404 | NSE Symbol : MARKSANS | ISIN : INE750C01026 | Industry : Pharmaceuticals |

(12-Nov-24 15:09) Marksans Pharma consolidated net profit rises 15.80% in the September 2024 quarter
(12-Nov-24 13:22) Marksans Pharma gains after Q2 PAT rises 16% YoY to Rs 97 cr
(23-Oct-24 17:41) Marksans Pharma to declare Quarterly Result
(21-Aug-24 20:00) Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules
(20-Aug-24 14:48) Marksans Pharma gets EIR from USFDA for Goa facility
(20-Aug-24 14:37) Marksans Pharma's Verna unit successfully completes USFDA inspection
(20-Aug-24 10:46) Marksans Pharma to convene AGM
(14-Aug-24 12:04) Marksans Pharma surges after Q1 PAT rises 29% YoY to Rs 89 cr
(14-Aug-24 07:54) Marksans Pharma consolidated net profit rises 29.26% in the June 2024 quarter
(02-Aug-24 16:12) Marksans announces receipt of marketing authorization for Levonorgestrel 1.5 mg Tablets

1 2 3 4 5 6 7 8 9 10

Marksans Pharma Ltd